BCL2 and neoplasm: From six tumour-bearing mice (n = 6) of each treatment group, TIFFalyzer and IHC Profiler quantitative immunohistochemical analysis for the level of expression of bcl-2 (Figure 6, Table 4, Table 5 and Table 6) and cox-2 (Figure 7, Table 7, Table 8 and Table 9) was performed as described in methods.